This transmigration requires Rap1 GTPase to activate integrin affinity 1 . We define a new model system for this process by demonstrating, with live imaging and genetics, that during embryonic development Drosophila melanogaster immune cells penetrate an epithelial, Drosophila E-cadherin (DEcadherin)-based tissue barrier. A mutant in RhoL, a GTPase homologue that is specifically expressed in haemocytes, blocks this invasive step but not other aspects of guided migration. RhoL mediates integrin adhesion caused by Drosophila Rap1 overexpression and moves Rap1 away from a concentration in the cytoplasm to the leading edge during invasive migration. These findings indicate that a programmed migratory step during Drosophila development bears striking molecular similarities to vertebrate immune cell transmigration during inflammation, and identify RhoL as a new regulator of invasion, adhesion and Rap1 localization. Our work establishes the utility of Drosophila for identifying novel components of immune cell transmigration and for understanding the in vivo interplay of immune cells with the barriers they penetrate. nature cell biology VOLUME 12 | NUMBER 6 | JUNE 2010 6 0 5 We thank D. Jukam, P. Kunwar, A-M. Sudarov, and S. Wang for help during the GAL4 enhancer screen, and D. Demy for input. We thank all the people who shared their reagents: for antibodies. We thank the Developmental Studies Hybridoma Bank developed with NICHD support and maintained by the University of Iowa for antibodies and the Bloomington Stock Center for flies. We are grateful for conversations with P. Rangan, P. Kunwar and many other members of the laboratory. We thank M. Dustin, S. Schwab and laboratory members for comments on the manuscript. We thank NICHD for supporting part of this work. R.L. is an investigator of the HHMI.
The ability of immune cells to penetrate tissue barriers is an essential component of their role in normal and aberrant human physiology. Leukocytes patrol throughout the body in the blood, and to attack an infection must move through the blood vessel's intervening endothelial wall 2 . Inappropriate activation of this transmigration can lead to damaging immune cell infiltrations that are involved in many medical conditions caused by autoimmunity 3, 4 . The ability to manipulate this process would have important medical implications.
Signals from infected tissue lead to changes in immune cell adhesion that underlie this specialized movement. On inflammation, endothelial cells in the vessel wall express selectins on their surface. Selectins transiently bind leukocyte surface proteins and promote an initial affinity of leukocyte integrin for endothelial ligands, causing immune cells to roll along the vessel wall. Cytokine signalling from inflamed tissue and other immune cells then triggers Rap1 GTPase activation in leukocytes 5 causing the Rap1 effectors RAPL and Mst1 to transit from a perinuclear region to the cell surface 6, 7 . This leads to a further increase of integrin affinity for endothelial ligands; leukocytes arrest rolling and actively migrate into the tissue, mostly at endothelial cell junctions 3 . Precisely how Rap1 effectors are relocalized and lead to integrin activation is unknown.
Haemocytes, Drosophila immune cells, have proved to be an excellent system to analyse guided cell migration. The predominant Drosophila immune cell, plasmatocytes, are macrophage-like, engulfing bacteria and viral invaders, phagocytosing dead cells 8 and responding to wounds and tumours [9] [10] [11] [12] [13] . They are guided by platelet-derived growth factor (PDGF)/ vascular endothelial growth factor (VEGF) receptor homologue, PVR, and its ligands Pvf2 and Pvf3 from their site of origin in head mesoderm along three main routes: towards the tail, along the ventral nerve cord and along the dorsal vessel 12, 14, 15 . Because of the open circulatory system of Drosophila, haemocytes need not penetrate an endothelial barrier to reach infections 10 . However, by examining plasmatocyte migration in live embryos during development, we discovered that Drosophila haemocytes invade an epithelial barrier as they move from the head region into the tail. We find that specific strategies for invasive immune cell transmigration such as the employment of integrins and Rap1 are conserved with vertebrates. Thus, Drosophila possesses a specific invasive migratory step, which is now amenable to unbiased genetic analysis.
To determine if haemocytes penetrate tissue barriers during their normal developmental migration, we examined fixed embryos expressing green fluorescent protein (GFP) from the haemocyte-specific GAL4 driver srpHemo 14 . We visualized haemocytes with anti-GFP antibodies, nuclei with 4,6-diamidino-2-phenylindole (DAPI) and surrounding tissues with anti-DE-cadherin antibodies. We observed haemocyte migration from the head region into the tail at stage 11 and 12 from lateral ( Supplementary Information, Fig. S1a -c) and dorsal directions ( Fig. 1a-f ). Haemocytes initially encounter a barrier of tail epithelial cells ( Fig. 1a, d ; arrows). However, as haemocytes infiltrate they break the junctions that hold the cells together ( Fig. 1b , e; arrows) and stream into the tail (Fig. 1c , f).
To directly observe haemocytes live while they are moving through surrounding tissues, all cell surfaces were labelled with a DE-cadherin-GFP fusion and all haemocytes with srpHemoGal4 driving UAS-GFP. Seen in lateral views, haemocytes enter on the underside of the tail and push between ectodermal epithelia and neighbouring mesoderm before germ-band retraction commences ( Supplementary Information, Fig. S1d , Movie S1). Movies of dorsal views revealed that haemocytes penetrated the epithelial barrier at the tail's edge and then moved between the hindgut and the surrounding cells ( Fig. 1g and Supplementary Information, Movie S2). Haemocytes displayed chain migration also seen in highly metastatic cancers 16 (Fig. 1h ) (Supplementary Information, Movie S3). We conclude that haemocytes migrate invasively into the tail during embryonic stages 11 and 12.
To determine if this invasive movement into the tail utilizes a specialized cell biological programme, we screened for mutants that specifically affect this step. A viable transposon insert, pGawB ( Supplementary  Information, Fig. S2a ), was identified in rhoL 17 . In sequence alignments RhoL clusters within a branch of the Rho family that contains Rac, Cdc42, and the less-characterized Rho proteins ( Supplementary  Information, Fig. S2b ). rhoL mRNA is expressed specifically in anterior head mesoderm where haemocytes originate, starting at stage 5 and continuing in all haemocytes through stage 11 ( Fig. 2a -c). Thereafter, rhoL mRNA ceases expression in haemocytes and expression begins in more posterior mesoderm (Fig. 2d ). The rhoL insert causes a strong reduction in rhoL transcript levels ( Supplementary Information, Fig. S2c,  d) . The phenotype is enhanced over Df(3R)by416, indicating that the insertion is a hypomorphic allele (data not shown). We generated a lethal excision, rhoL XA12 , which behaves as a null allele and strongly reduces the movement of cells into the tail at stage 11 and 12 ( Fig. 2e , f, m). On average only 4 ± 1 (n = 41) haemocytes reached the tail, compared with 31 ± 1 (n = 30) in wild type; 44% of embryos had no haemocytes in the tail, which is never observed in wild type. This causes an absence of haemocytes in the posterior nerve cord that persists through stage 14 ( Fig. 2h , i). The rhoL complementary DNA was expressed under the control of the haemocyte-specific 8-163GAL4 driver (see Methods) and achieved rescue ( Fig. 2g , j) with 27 ± 2 (n = 24) haemocytes in the tail at stage 12. We next assessed if RhoL affects haemocyte migration along their other noninvasive embryonic routes. Fixed rhoL XA12 mutant embryos displayed no defect in normal guided migration of haemocytes 12, 14, 15 along the anterior ventral nerve cord (data not shown) or dorsal vessel ( Fig. 2k-m ). We conclude that RhoL, a member of the Rho GTPase family, is expressed in haemocytes at the time of their migration into the tail, and is required specifically in haemocytes to permit this specialized movement. Thus, RhoL defines a separate invasive migratory step.
To analyse cellular aspects of haemocyte behaviour, we observed haemocytes expressing the actin-binding protein Moesin fused to GFP in live embryos. In wild type, haemocytes entered the tail fluidly ( Fig. 3a and Supplementary Information, Movie S4). Although haemocytes in rhoL XA12 mutants ( Fig. 3b and Supplementary Information, Movie S5) moved up to the junction with the tail (arrow in Fig. 3b , 0 min panel), and produced protrusions in its direction (arrow in Fig. 3b , 60 min panel) they never entered the tissue, unlike in wild type (compare asterisk in Fig. 3a, b ). As suggested by fixed tissue analysis ( Fig. 2i, l) , rhoL XA12 haemocytes exhibited normal guided migration along the anterior inner ventral nerve cord. Pvfs guide haemocyte migration 12 along the inner ventral nerve cord and both wild-type and rhoL XA12 haemocytes moved posteriorly in a directed manner ( Supplementary Information, Fig. S3a, b and Movies S6 and S7).
To determine if rhoL XA12 haemocytes had defects in actin structures that might prevent tail invasion, we created still-images of live haemocytes. We observed no differences in haemocyte lamellipodia or filopodia between wild-type and rhoL XA12 embryos ( Fig. 3c, d) . In contrast, Rac1 and Cdc42 are required in embryonic haemocytes to form broad and unipolar lamellae, respectively 11, 18 . Thus, although Cdc42 and Rac1 affect migratory actin structures, RhoL does not. RhoL is also not required for guided migration, but is specifically required for the invasive migration of haemocytes.
We wished to determine the nature of the barrier that haemocytes breach to move into the tail. The extracellular matrix (ECM) was one possibility; yet embryos lacking the two ECM metalloproteases in Drosophila, Mmp1 and Mmp2 (ref. 19) , or expressing inhibitors of ECM proteases displayed no migratory defects in haemocytes ( Fig. 3e and Supplementary Information, Fig. S3c-e ). Next, we tested if the barrier might consist of cellular junctions. Septate junctions form later, at stage 14, but spot adherens junctions mature into zonula adherens by stage 11 in the ectoderm 20 . If RhoL allows haemocytes to push apart adherens junctions to reach the tail, we reasoned that reducing the level of one junctional component, DE-cadherin, might rescue the rhoL phenotype. In the hypomorphic allele rhoL 10-161 , 20 ± 2 (n = 75) haemocytes moved into the tail (Fig. 3f, h) ; however when rhoL was combined with an allele of DE-cadherin, shg P34-1 , which has reduced expression owing to a transposon insertion in the 5ʹ UTR 21, 22 , the number of haemocytes moving into the tail increased to levels indistinguishable from rhoL heterozygotes (34 ± 3; n = 46 versus 33 ± 2; n = 23) ( Fig. 3g , h). An alternative interpretation of this rescue is that rhoL mutants display defects owing to elevated levels of DE-cadherin in haemocytes. However, we did not observe appreciable haemocyte expression of DE-cadherin in either wild type or the null allele rhoL XA12 ( Supplementary Information,  Fig. S3f-g" ). We therefore conclude that RhoL mediates penetration of haemocytes through a DE-cadherin-containing barrier, most likely the zonula adherens. Vertebrate leukocytes utilize Rap1 to regulate integrin and move through endothelial barriers 1, 5 . To assess whether Drosophila haemocytes require Rap1 for invasive migration we examined mutants in dizzy, a GTP nucleotide-exchange factor (GEF), which is required for Rap1's activation of integrin-dependent adhesion in haemocytes 23 . The number of haemocytes that entered the tail decreased ( Fig. 4a, b, d) in dizzy∆1 null mutants. Rap1 mutant embryos were not assessed, owing to their severe developmental defects 23 . Like rhoL, dizzy is specific for invasive migration into the tail and does not affect general guided migration along the dorsal vessel ( Supplementary Information, Fig. S4 ) or ventral nerve cord (data not shown). To further examine the analogies between vertebrate leukocyte vessel transmigration and Drosophila haemocyte tail invasion, we assessed strains mutated in the inflated gene, which encodes an α-integrin subunit expressed in the mesoderm where haemocytes are specified [24] [25] [26] . Fewer haemocytes were observed migrating into the tail in inflated null mutants (Fig. 4c, d) , but there was no decrease in dorsal vessel ( Supplementary Information, Fig. S4 ) or ventral nerve cord migration (data not shown). We conclude that haemocytes utilize the Rap1 pathway and integrins for penetrating into the tail, and thus exhibit molecular parallels with vertebrate immune cells moving through blood vessel walls.
These data suggest that RhoL acts with Dizzy and Rap1 to modulate integrin function to permit invasive haemocyte migration. To determine where in the pathway RhoL functions, we utilized an integrin-dependent haemocyte-clustering assay 23 ; adhesion is induced by expression of a dominant-active (DA) form of Rap1, Rap1 V12 , which bypasses the need for the Dizzy GEF. Wild-type haemocytes do not congregate together in great numbers (Fig. 5a, e ), whereas haemocytes expressing Rap1 DA form large, tightly associated masses of cells (Fig. 5b, e ). Rap1 DA -induced haemocyte clustering is abolished in the presence of the rhoL 10-161 allele (Fig. 5c, e ). When RhoL was overexpressed, the same numbers of haemocytes in masses were observed as after Rap1 DA expression ( Fig. 5d, e) , with similar fractions of each haemocyte's surface touching another haemocyte ( Fig. 5, legend) . We conclude that RhoL can regulate adhesion in this assay. To determine if RhoL functions in the same pathway with Dizzy and Rap1 during normal haemocyte movement, dizzyΔ1 rhoL 10-161 double mutants were created, but there was no additive effect (Fig. 4d) . These results show that Rap1 facilitates activation of integrin during invasive migration, and that this step is mediated by RhoL.
To determine how RhoL affects Rap1 activity, we examined a Rap1-GFP fusion expressed from the rap1 promoter 27 . In wild-type stage-11 and -12 embryos, Rap1 was observed in cytoplasmic concentrations in 11 ± 1% of wild-type haemocytes (n = 33 embryos) ( Fig. 5f, g) . The number of these concentrations was markedly increased in rhoL embryos, to 30 ± 2% (n = 30 embryos) of haemocytes ( Fig. 5h, i) . Changes in Rap1 localization were examined in haemocytes at higher magnification. In wild-type embryos we observed Rap1 mostly at the leading edge during tail invasion ( Fig. 5j-l) . In rhoL 10-161 mutant embryos Rap1 was located not at the membrane but in a large, roundish, intracellular concentration that excluded cytoplasm ( Fig. 5m-o) . The Rap1 concentration is not due to phagocytosis of neighbouring cells, because spectrin, which is expressed in the surrounding tissues, but not in haemocytes, does not colocalize with Rap1 (data not shown). We conclude that RhoL mediates proper Rap1 localization to permit invasive migration into the tail.
These results show that the developmental movement of Drosophila haemocytes requires invasive migration. Haemocytes penetrate the epithelial barrier caused by the tail folding against the head during germband extension. Vertebrates also seem to require invasive migration of immune cells during development; recent studies show that haematopoietic stem cells are born in mesoderm underneath the dorsal aorta and must migrate into it to eventually colonize the foetal liver 28 . We propose that the ability of immune cells to move through an epithelial barrier evolved before closed circulation within blood vessels did.
We also identify a pathway in Drosophila that is required specifically for this invasive migratory step. This requires the Rap1 GEF 39 36 20 37 75 0 dizzy∆1/Df rhoL WT dizzy∆1 inflated dizzy∆1 rhoL No Dizzy, the α-integrin Inflated and the RhoL GTPase just in this type of migration; this work and that of others orders their function. The following model is proposed based on our current findings ( Fig. 5j) : when haemocytes encounter an epithelial barrier, a pathway for invasion is activated. The Dizzy GEF converts Rap1 to its active GTP form 23 . However, Rap1-GTP cannot induce integrin activation unless RhoL is present to promote Rap1 localization to the leading edge, where Rap1 increases integrin affinity, as has been demonstrated in vertebrates 29 . The lack of basement membrane in electron microscopy studies 30 argues that Inflated is not binding to the ECM during tail invasion. We posit that Inflated binds another membrane protein (akin to the binding of intercellular adhesion molecule observed in vertebrates 31 ), or DE-cadherin itself, to facilitate transit between epithelial cells. Although it cannot be excluded that haemocytes exert force on epithelial cells to pry them apart, our observations ( Supplementary Information, Movie S2 ) favour the model that haemocyte integrin binding to an epithelial cell surface molecule induces a signalling pathway that decreases either the affinity or levels of cadherin-containing junctions. During their migration into regions of the embryo, other than the tail, haemocytes need not penetrate an epithelial barrier, and migrate along the surface of mesodermal or epithelial cell types.
In conclusion, we have provided the first evidence for modulation of Rap1 localization during epithelial penetration and for the involvement of a Rho GTPase homologue in controlling this shuttling. Chemokine signalling utilized during endothelial transmigration of vertebrate immune cells causes the Rap1 effectors RapL and Mst1 to leave an intracellular compartment in in vitro studies 6, 7 ; however, whether Rap1 localization changes is untested. T-cell receptor activation induces Rap1 trafficking from a perinuclear compartment to the cell surface to increase integrin binding, but how this shuttling is regulated is unclear 29, 32 . A Rho GTPase could control this process. In phylogenetic analyses ( Supplementary Information, Fig. S2b ) RhoL lies within a branch containing two Rhos involved in intracellular trafficking; RhoJ/TCL regulates early endocytosis and RhoQ/TC10 modulates exocytic vesicle fusion 33, 34 . This raises the possibility that RhoL acts as a switch to regulate trafficking of Rap1-containing vesicles in Drosophila and that RhoJ and/or RhoQ do the same in vertebrates. Drosophila immune cells' invasive migration displays striking similarity to vertebrate immune cells' extravasation in pursuit of infection. Both require Rap1 and integrin and do not seem to utilize MMPs 30 . Both must traverse a cadherin-containing barrier 31 . In both vertebrate and Drosophila immune cell migration, integrin is not needed for general interstitial migration 35 . We propose that during inflammation vertebrate immune cells move through an endothelial barrier by recapitulating the cell biological programme originally evolved for developmental migration through epithelia. We have found many other mutants in our screens that affect tail invasive migration, and have human homologues. We are thus encouraged that further examination of this new model for immune cell transmigration will provide novel insight into the cell biological controls that mediate this medically important process. Flies were grown on an agar, cornmeal, molasses and yeast mixture containing Tegosept mould inhibitor (Sigma), 1% methanol and 0.4% propionic acid. Embryos were collected on plates made from apple juice, sugar, agar and Tegosept.
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The full genotype of the embryos shown were: Fig. 1 (a-c) and Fig. S1 (a-c) : srpHemoGAL4 UAS-GFP. Fig. 1 (d-e ) and Fig. S1 (d) : ubi:shg-eGFP; srpHe-moGAL4 UAS-GFP. Fig. 2 (a-d) and Fig. S2 (d) : Oregon R. Fig. 2 (e, h, k, m) and Fig. 4 (a, d) , Fig. S3 (f-f "), and Fig. S4 (a, d) : 8-163GAL4 UAS-lacZ. Fig. 2 (f, i, k, m), and Fig. S3 (g-g"): 8-163GAL4 UAS-lacZ; rhoL XA12 . Fig. 2: (g, j, m) 8-163GAL4 UAS-lacZ; rhoL XA12 UAS-rhoL, Fig. 2: (m) 8-163GAL4 UAS-lacZ; rhoL XA12 / Df(3R) by416. Fig. 3 (a, c) and Fig. S3 (a) : 8-163GAL4 UAS-Moe-GFP. Fig. 3 (b, d) and Fig. S3 (b): 8-163GAL4 ; rhoL XA12 UAS-Moe-GFP. Fig. 3 (e) and Fig. S3 (c) : cn mmp2 W307 bw sp mmp1 Q112 /Cyo ftz:lacZ; srpHemoGAL4 UAS-CD2, Fig. 3 (e) and Fig. S3 (d) : cn mmp2 W307 bw sp mmp1 Q112 ; srpHemoGAL4 UAS-CD2. Fig. 3 (e) and Fig. S3 (e): srpHemoGAL4 UAS-GFP/ UAS-RECK; srpHemoGAL4 UAS-GFP/ UAS-TIMP. Fig. 3 (f, h) and Fig. 4 (d) : rhoL 10-161 GAL4 UAS-lacZ. Fig. 3 (g, h) : shg P34-1 ; rhoL GAL4 UAS-lacZ. Fig. 4 (b, d) and Fig. S4 (b, d) : dizzyΔ1; srpHe-moGAL4 UAS-CD2, Fig. 4 (c, d) and Fig. S4 (c, d) : inflated B2 ; 8-163GAL4 UAS-lacZ. Fig. 4 (d GAL4 UAS-lacZ. Fig.  5 : (a, e) srpHemoGAL4 UAS:CD2, (b, e) UAS-rap V12 ; srpHemoGAL4 UAS-CD2, (c, e) UAS-rap V12 ; rhoL GAL4 UAS-lacZ, (d, e) 9-1UAS-rhoL; srpHemoGAL4 UAS-CD2, (f, g, j-l) rap1-GFP; srpHemoGAL4 UAS-CD2, (h, i, m-o), rap1-GFP; rhoL GAL4 UAS-lacZ. Fig. S2 (c, d) : rhoL GAL4.
Haemocyte driver screen and 10-161 insert site localization. Males from GAL4 enhancer trap lines containing the pGawB vector were individually crossed to females carrying UAS-lacZ and the resulting embryos were stained with X-Gal to visualize expression. Lines were selected as possibly expressing in haemocytes based on the characteristic triangular early haemocyte pattern. Line 8-163 which showed normal haemocyte migration was utilized as a driver. Line 10-161 showed a defect in haemocyte migration into the tail. To determine the location of the 10-161 insert, the genomic region flanking the insertion site was amplified by inverse PCR (BDGP protocol) on MspI or Sau3A restricted genomic DNA (using GawB5ʹout and GawB5ʹin primers for the 5ʹ end, and GawB3ʹint4 and Pry1 primers for the 3ʹ end), sequenced and compared to the Drosophila genome. We mapped the insert to the promoter of the rhoL gene, 5 bp upstream of the transcript start. P element excision and RhoL rescue. Independent rhoL excision lines (100) were created by crosses to the Δ2-3 transposase and balanced over TM3Sb. Sixteen lethal excisions were identified, nine of which retained their lethality over Df(3R)by416 which removes RhoL. Primers (synthesized by IDT) located just next to the rhoL open reading frame (ORF) and 2 kb upstream of the rhoL transcriptional start site were utilized to characterize the extent of the excision. Primer sequences were: rhoL ORF 5ʹ: 5ʹ-CTGTGGAGCGAGTACG-3ʹ; rhoL ORF 3ʹ: 5ʹ-TGACGGCGAACATAAC-3ʹ; rhoL promoter 5ʹ: 5ʹ-GCGGAGCACTAAGGAG-3ʹ; rhoL promoter 3ʹ: 5ʹ-TGATTCGCTGTTCCAG-3ʹ. None of the excisions extended into the rhoL ORF, and all but one did not extend past the midpoint between the rhoL transcriptional start site and that of the neighbouring gene. Genewiz Inc. did the sequencing.
To create a RhoL rescue construct containing the entire ORF (231-803 base pairs after start of the cDNA) under the inducible control of UAS, the SD05212 rhoL cDNA was amplified with primers that encompassed the region from 51 bp to 890 bp. The primers contained an Eag1 site on the 5ʹ end and an XhoI site on the 3ʹ end to facilitate cloning into pUAST. Genetic Services created transgenes of these constructs. Rescue of the original rhoL insertion and the rhoL XA12 excision phenotype was tested with three independent UAS-rhoL insertions on the second chromosome. 
